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ABSTRACT 
 
 
An in vitro model of Alzheimer’s disease (AD) is required to study the poorly understood 
molecular mechanisms involved in the familial and sporadic forms of the disease. Animal 
models have previously proven to be useful in studying familial Alzheimer’s disease (AD) 
by the introduction of AD related mutations in the animal genome and by the 
overexpression of AD related proteins. The genetics of sporadic Alzheimer’s is however 
too complex to model in an animal model. More recently, AD human induced pluripotent 
stem cells (hiPSCs) have been used to study the disease in a dish. However, AD hiPSC 
derived neurons do not faithfully reflect all the molecular characteristics and phenotypes 
observed in the aged cells with neurodegenerative disease. The truncated form of nuclear 
protein Lamin-A, progerin, has been implicated in premature aging and is found in 
increasing concentrations as normal cells age. We hypothesized that by overexpressing 
progerin, we can cause cells to ‘age’ and display the neurodegenerative effects observed 
with aging in both diseased and normal cells. To answer this hypothesis, we first generated 
a retrovirus that allows for the overexpression of progerin in AD and non-demented control 
(NDC) hiPSC derived neural progenitor cells(NPCs). Subsequently, we generated a pure 
population of hNPCs that overexpress progerin and wild type lamin. Finally, we analyzed 
the presence of various age related phenotypes such as abnormal nuclear structure and the 
loss of nuclear lamina associated proteins to characterize ‘aging’ in these cells.  
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INTRODUCTION 
1.1 Human Pluripotent Stem Cells 
Tissue culture was developed in the early 1900s to study cellular response to normal 
and experimental conditions in a controlled environment. Since then, cell culture has 
evolved at a rapid pace allowing researchers to study individual cell phenotypes and 
genotypes to improve our understanding of human diseases and develop therapies to treat 
them. Primary cells derived from patients to study disease are generally terminally 
differentiated cells that do not expand indefinitely in vitro.  Stem cells are characterized by 
their ability to self-renew and differentiate into specialized cell types. Based on their 
differentiation potential, stem cells can be multipotent (can differentiate into only a few 
cell types of the body), or pluripotent (can differentiate into all three germ layers) etc. In 
1963, McCulloch and Till discovered the first human adult multipotent stem cells in the 
bone marrow, which regulate tissue homeostasis and damage repair in the body (Becker et 
al., 1963). However, these cells are rare, difficult to isolate and expand in vitro, and have 
a limited differentiation potential. Human embryonic stem cells (hESCs) and induced 
pluripotent stem cells (hiPSCs) are classified as human pluripotent stem cells (hPSCs), or 
a cell type that can differentiate into any cell type of the human body. hESCs are obtained 
from the inner cell mass of a human embryo and can propagate indefinitely under 
optimized cell culture conditions. As the extraction of the inner cell mass from the 
blastocyst destroyed the embryo, hESC culture was plagued with ethical controversies. 
hiPSCs resemble hESCs, but as they are generated by the overexpression of pluripotency 
factors in adult somatic cells, they provide an acceptable alternative to the controversial 
hESCs (Takahashi et al., 2007). As these cells can be derived from the somatic cells of a 
 2 
diseased patient and then be differentiated into a specific cell type that demonstrates the 
diseased phenotype, these cells provide the most reliable in vitro snapshot of the 
mechanism (Soldner and Jaenisch, 2012). Human iPSCs led down the neuroectodermal 
lineage generate a population of multipotent stem cells called human neural progenitor 
cells (hNPCs), that are capable of indefinite expansion and have the potential to 
differentiate into various cell types of the central nervous system (Moya et al., 2014). These 
cells can be patterned to specific regions of the brain to yield a homogenous population of 
cells that can be differentiated into functional mature neurons with little to no 
tumorigenicity (Brafman, 2015).  
1.2 Alzheimer’s Disease  
Alzheimer’s disease (AD) is a progressive neurodegenerative age related disorder that 
has recently been shown to the third leading cause of death in the United States, after heart 
disease and cancer (James et al., 2014; Weuve et al., 2014). An early diagnosis for AD, the 
most common form of dementia is associated with increased survival time (Brookmeyer et 
al., 2011). A recent study indicates that the elimination of the AD pathology could reduce 
the prevalence of dementia by  up to 50%, nearly 2.4 million cases by the year 2050 
(Brookmeyer et al., 2016). The hallmarks of AD pathology include the aggregation of 
amyloid-beta (Aβ) plaques, neurofibrillary tangles of hyperphosphorylated tau protein, and 
neurodegeneration (Vickers et al., 2016). Although the exact mechanism of AD remains 
unclear, genetic mutations in the amyloid precursor protein (APP), Presenilin 1 (PSEN1), 
and Presenilin 2 (PSEN2) genes, that cause the early-onset familial AD (FAD) have been 
identified (Goate et al., 1991; St George-Hyslop et al., 1987; Sherrington et al., 1995; St 
George-Hyslop et al., 1992; Sherrington et al., 1996). A majority of the cases however are 
 3 
the late-onset sporadic manifestation of AD (SAD), associated with various genetic and 
environmental risk factors. Apolipoprotein E (APOE) is one such genetic risk factor, the 
presence of an E4 allele of APOE is associated with an increased risk of developing AD 
(Kim et al., 2009). The presence of the more common E3 allele does not alter the risk of 
developing AD, whereas the E2 allele decreases the risk (Liu et al., 2013).  
1.3 Alzheimer’s disease modelling 
AD models are crucial to understand the underlying disease mechanism and 
subsequently evaluate the efficacy of proposed therapeutics. In vitro iPSC-derived neurons 
from sporadic and familial Alzheimer’s disease (SAD, FAD) patients are perhaps the most 
representative snapshot of the diseased state. Genetically modified knockout mice have 
been used to study the less prevalent familial form of the disease (Yang et al., 2000). A 
triple transgenic mouse model harboring APP, PSEN and Tau mutations was developed to 
study the interactions between Aβ and Tau and as well as their effects on the synapse (Oddo 
et al., 2003). However, owing to its genetic complexity, a model for the more common, 
late-onset sporadic form of AD is yet to be developed (Piaceri et al., 2013).  With the 
discovery of the OSKM transcription factor cocktail to reprogram somatic cells into 
induced pluripotent stem cells(iPSCs), we are closer to patient specific disease models than 
ever before (Takahashi et al., 2007). 
1.4 Stem cell reprogramming and age 
The induction of pluripotency in adult somatic cells has been shown to reset the cellular 
age to a fetal state. Reprogrammed iPSCs demonstrate increased telomere length and 
mitochondrial fitness, closer to an embryonic stem cell, compared to their somatic parental 
cell (Marion et al., 2009). However, cellular hallmarks of aging such as shortened telomere 
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length, increased reactive oxidation species (ROS) in mitochondria, loss of 
heterochromatin, disruption in nuclear organization and increase in DNA damage etc. are 
not recapitulated upon terminal differentiation (Lapasset et al., 2011; Miller et al., 2013) . 
To model a progressive age-related neurodegenerative disorder such as Alzheimer’s using 
patient derived iPS cells in vitro, it is critical to reintroduce the effects of aging (Figure 1-
2). Aging cells using chemical stressors and toxins reintroduces phenotypes such as DNA 
damage and elevated ROS but fails to account for the protective mechanisms that these 
cells might use to counteract the same. Carbonyl-cyanide 3-chlorophenylhydrazone (3Cph; 
Sigma, C2759), a chemical stressor, is used in this study to induce the production of ROS 
in wildtype and transduced hNPCs to validate the increased production of ROS in aged 
cells.   
1.5 Progerin induced aging 
Hutchinson-Gilford progeria syndrome (HGPS) is a disease characterized by 
accelerated premature aging, most commonly due to a point mutation in the gene encoding 
the nuclear envelope protein lamin (Scaffidi and Misteli, 2006). The silent point mutation 
activates a cryptic splice site in exon 11 of LMNA generating a progerin mutant with a 
deletion of 150 nucleotides (Figure 1-3). In a normal cell, the farnesylation of the wild 
type lamin protein allows for its localization to the nuclear envelope, after which the 
farnesyl group is cleaved. The 50-amino acid deletion in the progerin mutant protein 
however leads to a loss in the cleavage site of the farnesyl group, and it remains attached 
to the mature protein on the nuclear envelope (Capell et al., 2007). The expression of 
mutant progerin is associated with abnormalities in nuclear morphology and function, 
including the downregulation of nuclear proteins like LAP2a, HP1g, RANBP17 (Mertens 
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et al., 2015; Scaffidi and Misteli, 2005). Struder et al. demonstrate that the ectopic 
expression of progerin in neurons derived from iPSCs of a Parkinson’s patient restores the 
hallmarks of aging in the cell (Miller et al., 2013). We propose to examine the effects of 
overexpressing progerin in AD patient derived NPCs on cellular age. 
1.6 Gene delivery  
Researchers use gene delivery to introduce exogenous genetic information or to edit 
endogenous genes to generate iPSCs, induce their differentiation, or to recapitulate 
diseased phenotypes in patient-derived cells (Nayerossadat et al., 2012). Genetic elements 
can be delivered to cells using viral or non-viral methods that can result in the integration 
of the gene, or its transient expression in the cell. Retroviruses are RNA viruses that infect 
dividing cells and allow for stable integration at random insertion sites in DNA. An outer 
lipid envelope containing viral glycoproteins encapsulates two copies of positive sense 
RNA (Figure 1-4). After the viral glycoproteins recognize and bind to cell surface 
receptors, the virus fuses with the membrane and is endocytosed to release the contents 
into the cytoplasm (Figure1-4). The viral RNA is then reverse transcribed by a viral reverse 
transcriptase enzyme in the cytoplasm of the cell and the resulting DNA is translocated to 
the nucleus of the cell during mitosis (Coffin, 1992). In our system, the viral transfer vector 
is driven by the SV40 promoter and includes a green fluorescent protein (GFP) tag and a 
puromycin cassette to allow for the selection of transduced cells. (Figure1-5, A). A 
retrovirus to deliver the transfer plasmid can be generated by the co-transfection of a 
packaging cell line, such as the HEK 293Ts, with viral plasmids (packaging, envelope and 
transgene of interest) (Figure1-5, B).  
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Figure 1-1: Human Pluripotent Stem Cells  
Stem cells are characterized by the ability to self-renew and differentiate into specialized 
cell types (A). Stem cells derived from the inner cell mass of the blastocyst and 
reprogrammed from adult somatic cells are classified as human pluripotent stem cells 
(hPSCs) that can differentiate into cell types of all three germ layers (B).  
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Figure 1-2: hPSC reprogramming and disease modelling 
Hallmarks of aging are observed to be reversed upon reprogramming(A-B). For example, 
nuclear morphology is uniform, mitochondrial function is restored, telomeres are 
lengthened, DNA damage is reduced and structural proteins (RANBP17, LAP2A, 
PCDH10 etc.) are upregulated to restore nuclear organization. Currently available hPSC 
models of Alzheimer’s disease do not recapitulate all early and late phenotypes that 
manifest in familial AD (FAD) and sporadic AD (SAD) (C). 
 8 
	
 
 
Figure 1-3: Mutant Lamin-A processing in HGPS patients 
A silent mutation in LMNA gene leads to the activation of a cryptic splice site causing the 
aberrant processing and mutant splicing of the lamin transcript. A 150 nucleotide deletion 
in the transcript due to mutant splicing generates the progerin protein that lacks a cleavage 
site for the farnesyl group (Capell et al., 2007).  
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Figure 1-4: The structure and replication cycle of a viral particle.  
Based on viral tropism, the envelope of the virus is recognized by cell surface receptors 
leading to membrane fusion. Once inside the cytoplasm, the reverse transcription of viral 
RNA produces complementary DNA (cDNA) molecules that then translocate to the 
nucleus. This is followed by the integration of the viral cDNA into the host genome, 
generating the provirus. Viral mRNA is then transcribed within the nucleus, and 
subsequently the host cell machinery translates viral protein in the cytoplasm, including 
the expression of envelope proteins on the cell membrane. Following the packaging and 
assembly of a viral particle, it matures upon exit from the host cell by budding. (Figure 
adapted from Fanales-Belasio et al.,2010) 
 10 
Figure 1-5: Viral vector to overexpress transgene 
The viral LTR flanks the wt-lamin/progerin/GFP only transgene (A). The SV40 promoter 
drives the expression of the GFP tagged nuclear proteins and a puromycin cassette that 
allows for the selection of transduced cells. The co-transfection of the viral proteins in a 
packaging cell line generates virus (B). 
A 
B
A 
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2. MATERIALS AND METHODS 
2.1 Cell Culture  
All reagents used to prepare media were obtained from Life Technologies 
unless otherwise mentioned. Human Embryonic Kidney 293T cells were cultured on 
poly-L-ornithine (PLO) coated substrates. PLO plates were prepared by adding 10 
µg/mL PLO (Sigma, P3655) to tissue culture treated plates and incubating at 37°C for 
4 hours (h). The PLO solution was then aspirated and the plates were washed twice 
with DPBS before seeding cells supplemented in 293T media (DMEM, 10% FBS, 1% 
Pen/Strep). 
Human neural progenitor cells (hNPCs) were cultured on PLO-Laminin (LN) 
coated substrates. The method to coat these plates is as follows: PLO coated tissue 
culture plates were washed thrice with PBS and then coated with mouse LN (5 ug/mL) 
diluted in cold PBS. The plates were incubated for 4h at 37°C after which they were 
sealed with parafilm and stored at -20°C till use. The plates were washed twice with 
PBS before seeding cells suspended in neural expansion media (1X DMEM-F12, 1% 
(v/v) N2 supplement, 1% (v/v) B27 supplement, 1% (v/v) Glutamax, 1% (v/v) 
Pen/Strep) supplemented with 30ng/mL mouse FGF2 (Peprotech) and 30 ng/ml mouse 
EGF (Life Technologies).  During the passage of hNPCs, 5 uM Rho kinase inhibitor 
(Y-27632) was used to promote single cell survival. Freeze backs of cells were 
aliquoted in cryogenic vials (VWR, 10018-738) in freezing media containing 90% 
FBS, 10% DMSO (Sigma, D2650) and stored at -80°C in Mr. Frosty freezing 
containers for 24h before transferring to -150°C. 
 
 12 
2.2 Plasmid cloning and purification 
Bacterial stabs of the transfer vectors (Addgene # 17662, 17663, 10668), 
packaging vector (Addgene # 8449), and envelope vector (Addgene # 8454) were used 
to streak appropriate antibiotic resistant agar plates (Appendix C). The plates were 
incubated at 37 °C for 12 hours after which single colonies were picked to inoculate 3 
mL Millers LB media (Sigma, I8388) containing antibiotic. After 14 hours of growth 
at 37°C on a shaker at 225rpm, plasmids were extracted from 1 mL culture using 
Miniprep Kits (Qiagen, 27106). The identity of each plasmid was verified on a 1% 
agarose gel after a double-restriction-digest reaction using enzymes purchased from 
ThermoFisher. The verified plasmids were then grown up in a larger liquid culture 
(250mL) containing antibiotic. A DNA extraction kit (Macherey-Nagel, 74014) was 
used to extract high concentrations of plasmid DNA (>1 µg/uL). The plasmids were 
stored at -20 °C and thawed on ice before use. 
2.3 Transfection of HEK 293T  
2.3.1 Electroporation 
Healthy low passage HEK 293T cells were dissociated from 80% confluent 10 
cm plates using accutase. The dissociation enzyme was neutralized by the addition of 
an equal volume of DMEM and cells were pelleted by centrifugation at 200g. The cells 
were resuspended in 293T media (DMEM,10% FBS, 1% Pen/Strep) for counting. 
Tubes were set up with 5x106 cells per electroporation reaction and the cells were 
washed with 1x DPBS to remove traces of serum. The cells were resuspended in 100uL 
of buffer R of the 100 µL neon transfection kit.  The packaging (Addgene, 8454), 
envelope (Addgene, 8449) and transfer plasmid constructs (Addgene 17662, 17663) 
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were added to a sterile Eppendorf tube with 25µg total DNA per electroporation 
reaction (12.5µg x DNA, 8.25µg UMVC, 4.25µg VSVG). The DNA and cells were 
mixed by gently flicking the tube and cell-DNA mixture was electroporated using the 
100µL gold Neon tip at 1100V for 2 pulses of 20ms (ThermoFisher, MPK10025).  The 
transfected cells were transferred to a PLO coated 10cm plate containing 10mL of 
antibiotic free 293T media. At 24 hours, the media was switched to 293T media with 
antibiotic. Viral conditioned media was collected from 4x 10cm plates at 48 and 72 
hours post transfection. 
2.3.2 PEI Transfection  
Healthy low passage HEK 293T cells were dissociated from 80% confluent 10 
cm plates. The dissociation enzyme was neutralized by the addition of an equal volume 
of DMEM and cells were pelleted by centrifugation at 200g. The cells were 
resuspended in 293T media (DMEM,10% FBS, 1% Pen/Strep) and seeded at 5x106 to 
ensure 60-70% confluency on day 1. On the day of transfection, the media on the plate 
was changed to 293T cell culture media without antibiotic (DMEM, 10% v/v FBS). 
The packaging (Addgene, 8454), envelope (Addgene, 8449) and transfer plasmid 
constructs (Addgene 17662, 17663) were added to a sterile conical with 18µg total 
DNA per reaction (12.5µg x DNA, 8.25µg UMVC, 4.25µg VSVG). The DNA was 
diluted in DMEM and recommended volume of the polyethylinimine (PEI) reagent 
(PolySciences, 23966-2). After incubating for 15 minutes, the DNA-polymer 
complexes were added to the HEK293T cells. The media was changed 6h post 
transfection and conditioned cell supernatant was collected at 24 and 52 hours. 
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2.4 Concentration of virus 
The conditioned media was centrifuged for 5 minutes at 400g to remove any 
cell debris from suspension. It was then filtered through a 0.45 um cellulose acetate 
filter, after which 10mL of LentiX concentrator (ClonTech, 631231) was added to 
30mL of filtered conditioned media. The tube was inverted a few times to mix and 
incubated at 4°C for 40 minutes. The virus was pelleted by centrifugation at 1500g for 
45 minutes at 4°C. The viral pellet was gently resuspended in cold DMEM while 
ensuring no bubbles were introduced. 
2.5 Transduction of hNPCs 
Human neural progenitor cells were transduced with concentrated virus when 
they were 40% confluent on a 6 well PLO/Ln coated tissue culture plate. Transduction 
efficiency was enhanced by the addition of 8 ug/mL of polybrene (Sigma, H9268-5G). 
The media was changed 24 hours post infection and transduction efficiency was 
evaluated 72 hours post infection using flow cytometry. The cells were passaged to a 
12 well plate and antibiotic selection was started when cells were 80% confluent using 
200ng/mL puromycin (Life Technologies, A11138-03).   
2.6 Flow cytometry  
Cells were dissociated in Accutase (Life Technologies, A1110501) for 5 min at 
37°C and broken up into single cells. The cells were then washed and resuspended in 
stain buffer (BD Biosciences, 554656) maintaining the cell count at < 1000 events/uL 
of buffer. Cells were analyzed on a FACSCanto (BD Biosciences) or ACCURI C6 (BD 
Biosciences). For GFP positive live cells, the FL1 channel was used to measure 
fluorescence intensity after gating appropriate non-fluorescent controls for forward and 
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side scatter.  To stain for histone methylation mark H3K27me3, cells were fixed for 30 
min on ice with BD Cytofix Fixation Buffer (BD Biosciences). After washing twice 
with stain buffer, the cells were permeabilized for 30 min on ice using BD Phosflow 
Perm Buffer III (BD Biosciences). Cells were then washed twice with stain buffer and 
one test volume of antibody (EMDMillipore, 07-499) was added for each 100 uL of 
cell suspension. Cells were incubated at 37°C for 30 min after which they were washed, 
and resuspended in stain buffer containing the secondary antibody for 30 min. The 
stained cells were then washed twice before flow cytometry analysis (gated with a 2° 
antibody only control). For measuring ROS, cells were incubated with MitoSOX™ 
Red (ThermoFisher, M36008;  5uM diluted in media) for 10 minutes at 37°C and 
resuspended in stain buffer. To induce stress, cells were treated with 3Cph (3.5uM) for 
48h prior to ROS quantification using flow cytometry. 
2.7 RNA Isolation from Brain samples 
Cortical brain samples from patients with no prior neurological diagnoses were 
obtained from sources listed in Appendix A. Samples were sliced into small sections 
using a sterile blade and forceps on a petridish placed on dry ice. The sections were 
collected in a microhomogenizer Eppendorf tube (Clontech, 9791A) and 800uL of cold 
TRIzol (ThermoFisher, 15596018) was added to homogenize the sample. The 
homogenized sample was placed at 65°C for 5 min and 200µL of chloroform was added 
to the sample while still warm. The sample was mixed by vigorous shaking for 30 
seconds after which it was placed on ice for 5 minutes. Following centrifugation at 
1000 rpm for 5 min the aqueous phase was transferred to a new tube. One volume of 
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70% ethanol was added to the sample and the RNA was then purified using the 
NucleoSpin RNA Kit (Macherey-Nagel, 740955).  
2.8 Quantitative PCR (qPCR)  
RNA was isolated from biological samples using the NucleoSpin RNA Kit 
(Macherey-Nagel, 740955). Reverse transcription of 1000ng of RNA was performed with 
the iScript RT Supermix (Bio-Rad). Quantitative PCR was run using the iTaq Universal 
SYBR Green Supermix (Bio-Rad) on a CFX384 TouchTM Real-Time PCR Detection 
System. A 2 min gradient to 95°C was followed by 40 cycles at 95°C for 5 s and 60°C for 
30 s. Primer sequences used in the assay are detailed in Appendix B. Gene expression was 
normalized to 18S rRNA levels. Delta Ct values were calculated as Ctarget-Ct18s. The 2-DDCt 
method was used to analyze raw data and calculate relative fold changes in gene expression 
(VanGuilder et al., 2008). 
2. 9 Immunofluorescence 
Prior to fixation, cells were washed twice with stain buffer (BD Bio- sciences). 
The cells were then fixed for 30 min at room temperature (RT) with BD Cytofix Fixation 
Buffer (BD Bio- sciences). After two washes with the staining buffer, the cells were 
permeabilized with BD Phosflow Perm Buffer III(BD Biosciences) for 30 min at 4°C. 
The cells were washed twice with stain buffer before incubating at 4°C overnight with the 
primary antibody for NESTIN. Following two washes with stain buffer the cells were 
incubated with secondary antibodies at RT for 1 h. DNA was stained with Hoechst 33342 
(2 µg/ml; Life Technologies) for 10 min at RT and then washed twice with stain buffer. 
Stained cells were imaged using an EVOS microscope (Life Technologies). 
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3. RESULTS 
3.1 OPTIMIZATION OF VIRUS PRODUCTION IN HEK 293T CELLS 
The vector map of the plasmids containing the wild type and mutant LMNA gene is 
described in Figure 1-4. The simian virus 40 (SV40) promoter drives the expression of the 
nuclear envelope protein tagged with a green fluorescent protein(GFP) reporter. The 
plasmid also contains a puromycin resistance cassette that allows for the antibiotic 
selection of transfected mammalian cells. The complete plasmid maps presented in 
Appendix -C contain the restriction enzyme sites that were used to verify the identity of 
the constructs using a double digest.   
3.1.1 Electroporation increased viral plasmid transfection efficiency in HEK293Ts 
The efficient delivery of viral plasmids to the HEK293T packaging cell line is 
critical to generate functional viral particles. The transient transfection of the 293T cells 
allows for the generation of viral particles that subsequently infect cells with virus encoding 
the GFP-expressing transgene. Thus, the transfection efficiency is an indicator of the titer 
of the virus in the cell supernatant. We compared the efficiency of gene delivery by 
electroporation with chemical transfection using polyethylenimine (PEI). Source plates 
transfected using electroporation displayed a higher transfection efficiency compared to 
PEI transfected HEK293Ts (Figure 3-1). The higher transfection efficiency of the GFP-
only source plates can be attributed to the smaller size of the transgene. 
3.1.2 Lamin/Progerin overexpression verified in 293T cells using qRT-PCR 
The activation of the cryptic splice site due to a point mutation in the lamin-A gene 
leads to the deletion of a 150 nucleotide deletion in the transcript, generating the progerin 
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protein (Eriksson et al., 2003). Primer pairs spanning across the splice site consensus 
sequence were used to verify the expression of full length wild type lamin (wt-lamin) and 
truncated (mutant) progerin (Scaffidi and Misteli, 2006). The ‘lam full’ primer pair spans 
from exon 9 through exon 11, across the consensus splice sequence. In lamin transfected 
cells, a 511 bp product is expected upon PCR amplification. However, in cells 
overexpressing progerin, a 150 bp deletion causes the expression of a truncated 361 bp 
product. The ‘prog mut’ primer pair detects part of exon 11- exon 12 that is discontinuous 
in wt-lamin, but yields an 87 bp product in progerin overexpressing cells. The 
overexpression of full length lamin/truncated progerin in infected HEK293Ts was 
confirmed by qRT-PCR. The products were run on a 4% agarose gel to improve band 
separation, as described in Figure 3-2. 
 
3.2 OPTIMIZATION OF VIRAL TRANSDUCTION IN HUMAN NEURAL 
PROGENITOR     CELLS (hNPCs)  
The stable integration of a transgene into the genome of a target cell can be achieved 
through retroviral transduction. The efficiency of viral transduction is dependent on the 
titer of functional viral particles infecting a cell. To generate virus, retroviral envelope and 
packaging plasmids are co-transfected with the transgene of interest into a packaging cell 
line like human embryonic kidney (HEK) 293T cells (Louis et al., 1997) (Figure 1-5). The 
HEK 293T cells are transformed with ~4.5kb of the adenoviral genome and can be used 
for the propagation of viral vectors. These cells are easily transfected and express the large 
T-antigen that binds to the SV40 promoter region of viral vectors and allows for the 
episomal replication and expression of the transfer plasmids. The 293T cells produce and 
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package viral components that mature as they bud out of the cell with host membrane, that 
now expresses viral envelope proteins. The cell supernatant of transfected 293Ts contains 
mature viral particles that proceed to infect other cells in order to propagate the viral cell 
cycle. The transfer plasmids are designed to be replication incompetent, or self-
inactivating, to address safety concerns involved in working with infectious viral particles. 
Self-inactivating vectors contain a deletion in their 3’long terminal repeat (LTR) promoter 
that is copied into the 5’LTR in viral progeny. This deletion prevents the replication in an 
infected cell, halting the propagation of the viral life cycle (Zufferey et al., 1998). As the 
wt-lamin and progerin constructs contain the GFP fluorescence reporter, the transduction 
efficiency of the hNPCs was quantified using flow cytometry and considered representative 
of the viral titer.  
3.2.1 Chemical concentration improves viral transduction efficiency 
The titer of virus in the harvested cell supernatant is dependent on a multitude of 
factors, including the health of the packaging cell line, the transfection efficiency, the 
transgene itself, and the method of storage (Tiscornia et al., 2006). The multiplicity of 
infection (MOI), or the average number of viral particles infecting each cell, can be 
increased by concentrating viral particles from larger volumes of cell supernatant.  Viral 
pellets can be resuspended in small volumes following high speed centrifugation in an 
ultracentrifuge (70,000g). As this specialized centrifuge was not readily accessible to us, 
we used a commercially available concentrating reagent. Virus can also be concentrated 
by adding chemical reagents to the cell supernatant that precipitate viral particles upon 
centrifugation at relatively low speeds (1,500g). Precipitation of the virus with the LentiX 
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chemical concentrator increased the viral titer, leading to ~15-fold increase in transduction 
efficiency (Figure 3-3).  
3.2.2 Polybrene induces increase in transduction efficiency 
Cationic lipopolymers like polybrene (hexadimethrine bromide) have been shown 
to increase retroviral transduction efficiency by reducing the electrostatic repulsive forces 
between a negatively charged cell and the negatively charged viral envelope (Davis et al., 
2002; Denning et al., 2013). Flow cytometry was used to quantify GFP as a measure of 
transduction efficiency both in the presence and absence of polybrene (Figure 3-4). The 
transduction of hNPCs with LentiX-concentrated GFP, Lam-GFP and Prog-GFP virus 
showed a marked increase in the presence of polybrene (8ug/mL). The higher increase in 
GFP-only virus transduction efficiency could be attributed to the relatively small size of 
transgene to be packaged. 
3.2.3 Antibiotic selection enriches for transduced hNPCs 
As transduction of hNPCs with the Lamin/Progerin-GFP virus conferred 
puromycin resistance to infected cells, the transduced cell population could be enriched 
using antibiotic selection. Following a kill curve to identify the optimal concentration of 
puromycin for selection, the cells were routinely passaged in the presence of antibiotic 
(0.2ug/mL). In the absence of antibiotic selection, the uninfected population of GFP-
negative cells stabilized. Cells passaged in puromycin were more than 40-fold enriched for 
the transduced GFP-positive population (Figure 3-5, A). Fluorescence activated cell 
sorting (FACs) was used to further isolate a pure population as the ratio of the transduced 
to non-transduced cells decreased with passaging post infection (Figure 3-5, B).  
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3.3 VALIDATION OF SELECTED hNPCs 
3.3.1 Confirming Lamin/Progerin expression in hNPCs using qRT-PCR 
The transduction of hNPCs with wild type lamin and progerin retrovirus leads to 
the stable expression of the nuclear envelope protein due to the genomic integration of the 
transgene. The expression of full length lamin (wt-lamin) and truncated lamin (progerin) 
was confirmed by qRT-PCR with the ‘lam full’ primer spanning the consensus splice 
sequence (Figure 3-6, A). The amplified products were run on a 4% agarose gel to improve 
band separation and detection of the 87 bp mutation specific sequence that is absent in 
Lamin-GFP hNPCs (Figure 3-6, A). The expression of progerin was ~1000 fold elevated 
in Progerin-GFP hNPCs compared to its expression in Lamin-GFP hNPC population 
(Figure 3-6, B). 
 
3.4 ASSAYS FOR AGING MARKERS IN hNPCs 
3.4.1 Progerin overexpression causes blebbing of nuclear envelope 
The identity of the transduced hNPCs was confirmed by immunostaining for the 
neurofilament marker NESTIN, that is expressed by neural stem/progenitor cells (Suzuki 
et al., 2010) (Figure 3-7, C-H). The mixed population of non-transduced wt hNPCs and 
Lamin-GFP/Progerin-GFP hNPCs expressed NESTIN. Progerin overexpressing cells 
display a non-uniform blebbed nuclear envelope (Scaffidi et al.,2005). The GFP tagged 
nucleus of wt-lamin expressing Lamin-GFP NPCs exhibit a uniform morphology (Figure 
3-7, A), whereas the progerin expressing Progerin-GFP hNPC nuclei display folding and 
blebbing of the nuclear envelope (Figure 3-7, B).  
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3.4.2 Progerin expressing hNPCs have higher levels of mitochondrial ROS 
Flow cytometry was used to quantify the mitochondrial reactive oxidation species 
(ROS) in Lamin/Progerin-GFP hNPCs.  Carbonyl-cyanide 3-chlorophenylhydrazone 
induced stress was used as a positive control to measure elevated ROS in Lamin/Progerin-
GFP hNPCs (Figure 3-8, B), with unstained hNPCs as the threshold for red fluorescent 
protein(RFP) signal (Figure 3-8, A). In the absence of the 3Cph, Progerin-GFP cells 
exhibit higher ROS than Lamin-GFP hNPCs (Figure 3-8, C). 
3.4.3 Elevated levels of repressive histone methylation marks in progerin 
expressing hNPCs 
Elevated levels of the repressive histone mark H3K27me3 have been observed in 
tissue from an adult mouse brain (Tang et al., 2014). We measured the level of the 
repressive histone mark in transduced lamin and progerin hNPCs using immunostaining 
for the H3K27me3 mark followed by flow cytometry analysis (Figure 3-9). The progerin 
overexpressing hNPCs exhibit a higher level of the histone mark compared to the wild 
type lamin expressing hNPCs. 
3.4.4 Tau 4R isoform absent in transduced hNPCs 
The Tau 3R/4R mRNA isoform ratio has been demonstrated to be about 1:1 in a 
normal adult human brain (Iovino et al., 2010). The expression of the 3R and 4R Tau 
isoforms was quantified in the Lamin/Progerin-GFP hNPCs using qRT-PCR. The 
amplified RT-PCR products were run on a 2% agarose gel to separate the two Tau isoforms. 
The adult brain sample showed 3R and 4R Tau expression, whereas the fetal brain and 
hNPC samples expressed the only the 3R isoform (Figure 3-10). 
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3.4.5 Progerin transduced hNPCs exhibit Lamin-GFP hNPC like expression levels 
of genes downregulated during aging 
Gene expression analysis of aged cells has revealed the downregulation of various 
genes involved in nuclear transport and cellular function (Mertens et al., 2015; Vidak et 
al., 2015). This was confirmed by examining the expression levels of these candidate genes 
in cortical samples from the human adult brain (16 - 93 years).  Following RNA isolation 
from fetal and adult brain tissue, cDNA was synthesized for qRT-PCR analysis to measure 
age related gene expression levels (Figure 3-11, A). The adult brain samples displayed the 
significant downregulation of 5 aging genes (CACNG4,FBN3,HP1g,NKAIN2,PCDH10) 
compared to the fetal brain (Figure 3-11, B). There was no significant difference in the 
expression levels of these genes in the Progerin-GFP hNPCs relative to the wt-lamin 
expressing hNPCs (Figure 3-11, C). RNA sequencing (RNA-Seq) analysis indicated the 
significant upregulation of 64 genes and significant downregulation of 102 genes in 
Progerin-GFP hNPCs compared to the Lamin-GFP and wt hNPCs (Figure 3-12). The 
candidate aging genes considered in Figure 3-11 however were not part of this 
differentially expressed subset.  
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Figure 3-1: Electroporation increased viral plasmid transfection efficiency in 
HEK293T compared to chemical transfection methods 
Flow cytometry data of HEK293T cells transfected with envelope, packaging and transfer 
(GFP, Lamin, Progerin) viral plasmids. The transfection efficiency, quantified by the 
number of GFP positive cells, was larger in the case of electroporation mediated gene 
delivery relative to the chemical transfection using PEI. 
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Figure 3-2: Truncated lamin expression in progerin transfected HEK293Ts 
(A) Primer pairs designed to verify the expression of full length (wildtype) lamin and 
truncated (Mutant) progerin (adapted from Scaffidi, P. and Misteli, T., 2006). The lam 
full primer pair spans across exon 9 and 11 across the consensus splice sequence. In 
the lamin transfected cells, a 511 bp product is expected to be PCR amplified. In cells 
overexpressing progerin, a 150 bp deletion causes the expression of a truncated product 
of 361 bp. The prog mut primer pair detects parts of exon 11-12 that is discontinuous 
in wild type lamin, but yields an 87 bp product in progerin overexpressing cells.  
(B) The overexpression of full length Lamin/truncated progerin in infected HEK293Ts 
was confirmed by qRT-PCR using primer pairs designed in (a).  The products were run 
on a 4% agarose gel to enhance band resolution. 
 
 
 
B
A 
A 
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Figure 3-3 Chemical concentration increases transduction efficiency  
(A)Transduction of human neural progenitor cells (hNPCs) with viral conditioned neural 
expansion media. (B) LentiX mediated concentration of cell supernatant. Transduction 
efficiency using no concentration (C) and LentiX (D) was measured using flow cytometry. 
A 
B 
C D
C 
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Figure 3-4 Transduction efficiency in the presence of polybrene 
Flow cytometry data indicating GFP positive population of cells as a measure of 
transduction efficiency of GFP, Lam-GFP and Prog-GFP viruses. The transduction 
efficiency was higher in the presence of polybrene (B) for all three viruses, compared to 
the no treatment control (A). 
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Figure 3-5 Puromycin selects pure population of transduced hNPCs 
Flow cytometry data of Lam-GFP and Prog-GFP virus transduced hNPCs. Pure 
populations of GFP positive transduced cells were obtained using puromycin selection(A). 
Lamin/ progerin hNPC population was enriched at passage 25 by FACs (B).  
 
A 
B 
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Figure 3-6 Truncated lamin overexpressed in Progerin-GFP hNPCs. 
(A) 4% agarose gel with qRT-PCR products with primers designed to detect full length 
(511 bp) and truncated lamin (361 bp) (Figure 3-2) in lamin and progerin hNPCs using 
the ‘lam full’ primer pair.  The expression of mutant progerin is confirmed by the 
presence of an 87 bp product with the ‘prog mut’ primer in Progerin-GFP transduced 
hNPCs. 
(B) Relative progerin expression in progerin-GFP transduced cells was ~1000 fold higher 
compared to progerin levels in lamin-GFP hNPCs. 
 
 
A B
A 
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Figure 3-7 Progerin overexpression causes blebbing of nuclear envelope. 
Epifluorescence microscopy images of wild type lamin-GFP (A) and progerin-GFP (B) 
transduced hNPC nuclei. The Progerin-GFP nuclear envelope. (scale=100um). 
Immunofluorescence images of NESTIN stained lamin(C-E)/progerin(F-H) hNPCs.  
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Figure 3-8 Progerin overexpression in hNPCs leads to elevated mitochondrial ROS. 
Flow cytometry analysis of Lamin/Progerin-GFP hNPCs to quantify mitochondrial 
reactive oxidation species (ROS).  Carbonyl cyanide 3-chlorophenylhydrazone-induced 
stress was used to measure ROS in Lamin/Progerin-GFP hNPCs (B), with unstained 
hNPCs as the threshold for red fluorescent protein(RFP) signal. In the absence of the 
chemical stressor, Progerin-GFP hNPCs exhibit higher ROS levels than Lamin-GFP 
hNPCs (C). 
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Figure 3-9 Progerin-GFP hNPCs display increased levels of repressive histone 
methylation marks 
Flow cytometry analysis of cells immunostained for the repressive histone methylation 
mark H3K27me3. hNPCs stained with secondary antibody only was used to gate the RFP 
positive histone marks(A). Progerin transduced hNPCs express high levels of the 
repressive epigenetic mark (C) compared to the Lamin-GFP cells (B).  
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Figure 3-10 Tau 4R isoform not Expressed in transduced hNPCs 
A 2% agarose gel containing the qRT-PCR products of fetal brain (12 weeks), adult brain 
(50-years), wt hNPCs, Lamin-GFP hNPCs and Progerin-GFP hNPCs for Tau gene 
expression. The 4R isoform is observed only in the adult brain sample, whereas all samples 
express the 3R Tau isoform. 
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Figure 3-11 Progerin transduced hNPCs exhibit Lamin-GFP hNPC like expression 
levels of genes downregulated during aging.  cDNA from fetal and adult brain tissue was 
used to measure age related gene expression levels of 9 genes (A). The gene expression of 
5 candidate aging genes was significantly reduced in the adult cortical brain samples 
compared to fetal brain gene expression levels (p<0.05) (B). The expression of aging genes 
in the Progerin-GFP hNPCs was not significantly different from Lamin-GFP hNPCs (C). 
Comparisons were made using Students t-test (p<0.05, 0.001,0.0001) 
A 
B
A 
C
A 
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Figure 3-12 RNA-Seq analysis reveals the differential expression of Progerin hNPCs  
RNA-Seq analysis of Lamin-GFP, Progerin-GFP and wt hNPCs. False discovery rate 
(FDR) adjusted differential gene expression of Lamin-GFP and Progerin-GFP transduced 
cells relative to the wild type hNPCs (A-B). Upregulation of gene expression on transgene 
overexpression is indicated in red and downregulation is indicated in green. The Progerin-
GFP hNPCs show significant differential upregulation of 64 genes and downregulation of 
102 genes compared to both the wild type and Lamin-GFP hNPCs (C). 
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4. DISCUSSION 
The maturation, or aging, of patient derived hPSCs is required to recapitulate the 
functional phenotypes observed in vivo. Although DNA damage and chemical stressors 
can be used to induce some of the biochemical markers associated with aging, the study of 
disease mechanism in such a model could be biased due to these external stresses. The 
prolonged constitutive overexpression of the progerin protein in hNPCs could affect the 
AD phenotype itself. This problem can be addressed with the development of a lentiviral 
system to inducibly express the progerin protein. This method would allow us to control 
the extent of overexpression of progerin and in turn, the age of the cell. The induction of 
the aged phenotype could also be achieved by introducing the progerin point mutation in 
the consensus splice-site of endogenous LMNA gene using CRISPR technology. 
In our study, we established a retroviral system to stably integrate the mutant LMNA 
gene, associated with accelerated aging in HGPS, into the genome of hNPCs. The 
constitutive expression of the mutant progerin protein at the progenitor stem cell stage was 
observed to induce some hallmarks of aging such as the blebbing of the nuclear envelope, 
elevated mitochondrial ROS, and high levels of the repressive H3K27me3 histone mark. 
The terminal differentiation of these progerin expressing hNPCs into cell types of the 
central nervous system could lead to the manifestation of the other age related phenotypes, 
including the expression of the 4R Tau isoform and the downregulation of nuclear transport 
proteins. The genes implicated in aging (RANBP17, LAP2A etc.) were downregulated in 
cortical neurons and the directed differentiation of hNPCs to this specific population is 
expected to recapitulate this phenotype. Additionally, these cells could recapitulate 
functional phenotypes missing in current models using both healthy and AD.  
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APPENDIX A 
TABLE 1: PRIMARY BRAIN SAMPLES USED FOR GENE EXPRESSION 
ANALYSIS 
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  Sample Source Age 
1 Fetal Brain   0 
2 Miami_004 
University of Miami Brain Endowment 
Bank 16 
3 Miami_008 
University of Miami Brain Endowment 
Bank 22 
4 13152 University of Pittsburg 23 
5 13095 University of Pittsburg 33 
6 09-35 CBL Banner Sun Health Research Institute 38 
7 13054 University of Pittsburg 48 
8 13068 University of Pittsburg 48 
9 13058 University of Pittsburg 50 
10 13032 University of Pittsburg 52 
11 09-50 CBL Banner Sun Health Research Institute 53 
12 13052 University of Pittsburg 66 
13 Miami_009 
University of Miami Brain Endowment 
Bank 70 
14 10-70 CBL Banner Sun Health Research Institute 74 
15 13-49 CBL Banner Sun Health Research Institute 75 
16 Miami_001 
University of Miami Brain Endowment 
Bank 79 
17 Miami_025 
University of Miami Brain Endowment 
Bank 87 
18 10-39 CBL Banner Sun Health Research Institute 93 
19 10-26 CBL Banner Sun Health Research Institute 95 
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APPENDIX B  
TABLE 2:  PRIMER PAIRS USED IN RT-QPCR 
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  Primer Name Primer sequence 
1 LMNA-RT9 FWD(Full/Trunc) GTGGAAGGCACAGAACACCT 
2 LMNA-RT12 RVS(Full/Trunc) GTGAGGAGGACGCAGGAA 
3 LMNA ∆150 exon12 FWD GCGTCAGGAGCCCTGAGC 
4 LMNA ∆150 exon12 RVS GACGCAGGAAGCCTCCAC 
5 LMNA-RTnorm e8 Forward GGTGGTGACGATCTGGGCT 
6 LMNA-Rtnorm e9 Reverse CCAGTGGAGTTGATGAGAGC 
7 qRanBP17#1 FWD GGATCCTGGATTGAGACGAA 
8 qRanBP17#1 REV GTGCTTCCAGGCTCGTTCTA 
9 qRanBP17#2 FWD CACTGAACCATGCAGTCTCG 
10 qRanBP17#2 REV GGGCTAGCCAACATCACTGT 
11 qRanBP17#3 FWD TCTGAATTACGTGGCATCACA 
12 qRanBP17#3 REV CCTCAAACCACCCCAACTTA 
15 PCDH10 #1 FWD CCTGGCATGGACTCTGTTCC 
16 PCDH10 #1 REV TAGCTGCCTCCACAATAGCTT 
17 PCDH10 #2 FWD GTTCCTGGCATGGACTCTGT 
18 PCDH10 #2 REV AGCTGCCTCCACAATAGCTTC 
19 LAP2α FWD TCCTTTGGGCAGTACCGAAC 
20 LAP2α RVS AGACCAACATGGCACTGTG 
21 HP1Gamma-2 FWD AGACTCCGGTCACTGTCCTC 
22 HP1Gamma-2 RVS ACTTGAAGAGCTATTACGTTCGC 
23 18S FWD GTAACCCGTTGAACCCCATT 
24 18S RVS CCATCCAATCGGTAGTAGCG 
25 TAU FWD AAGTCGCCGTCTTCCGCCAAG 
26 TAU RVS GTCCAGGGACCCAATCTTCGA 
27 CACNG4-3 FWD CCAACCTGACCATGGACGAC 
28 CACNG4-3 RVS TAGATCCCTTCGATGCAGCAC 
29 ZCRB1-2 FWD GCTACGAAGAGTCGGGGTTG 
30 ZCRB1-2 RVS CCACCACTCATTTCTTCAGGT 
31 FBN3-1 FWD GACTGACCCGGACAACTGAG 
32 FBN3-1 RVS AGAAGGGAGAGACCCCTGTC 
33 BPTF-2 FWD CAAATCGGAGAAGTCCAACGG 
34 BPTF-2 RVS CCAGTACCTCTTTGCCCTCC 
35 NKAIN2-2 FWD GGGCACCTATCCTGGCAAAT 
36 NKAIN2-2 RVS TCAGGATAAGGTCTGTTTCCTTTGA 
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APPENDIX C 
VECTOR MAP OF PROGERIN VIRAL CONSTRUCT 
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Progerin Viral Vector 
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Lamin Viral Vector 
 
 
 
(Addgene # 17662) 
